Development of a Cytokine-Modified Allogeneic Whole Cell Pancreatic Cancer Vaccine

Methods in Molecular Biology - United States
doi 10.1007/978-1-62703-287-2_9
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Humana Press

Related search

Disrupting Cytokine Signaling in Pancreatic Cancer

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2013English

Phase 1 Trial of Allogeneic Gene-Modified Tumor Cell Vaccine RCC-26/CD80/IL-2 in Patients With Metastatic Renal Cell Carcinoma

Human Gene Therapy
Molecular MedicineGeneticsMolecular Biology
2010English

Allogeneic Cell‑based Immunotherapy Combined With Chemotherapy and Targeted Therapy in Advanced Pancreatic Cancer With Metastases: A Case Report

Oncology Letters
Cancer ResearchOncology
2014English

Establishment of a Human Pancreatic Cancer Cell Line and Detection of Pancreatic Cancer Associated Antigen.

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1984English

Development of a Vaccine Targeting Triple-Negative Breast Cancer

2013English

A Novel Cancer Vaccine Strategy Based on HLA-A*0201 Matched Allogeneic Plasmacytoid Dendritic Cells

PLoS ONE
Multidisciplinary
2010English

Progress in the Development of a Cervical Cancer Vaccine

Therapeutics and Clinical Risk Management
Chemical HealthPharmacologySafetyMedicineToxicologySafety ResearchPharmaceutics
2006English

Antiangiogenic Cancer Therapy Using Peptide Vaccine for Patients With Advanced Pancreatic Cancer

Suizo
2010English

Mesothelin Is a Malignant Factor and Therapeutic Vaccine Target for Pancreatic Cancer

Pancreas
Internal MedicineEndocrinologyHepatologyMetabolismDiabetes
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy